US › Healthcare

Compugen (CGEN)

US · Healthcare · Biotechnology

$2.380.00%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$2.2M

Revenue YoY

-4.7%

Net profit

$-7.7M

Profit YoY

-6.8%

EPS

$-0.08

EPS estimate

$-0.08

Net margin

-352.4%

EPS came in at -0.08 against a street estimate of -0.08 — a beat of 0.0%.

Key statistics

Market cap

$222.3M

P/E

6.2

Forward P/E

12.4

P/B

2.33

Book value

$1.01

EPS (TTM)

$0.38

52-week high

$3.23

52-week low

$1.29

50-day MA

$2.29

200-day MA

$2.08

Beta

2.77

Analyst view

Analysts rate Compugen a strong buy (4 buy, 0 hold, 0 sell out of 4) with an average price target of $4.60.

Shareholding

Insiders

2.11%

Institutions

15.40%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Compugen — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.